Hexigone Inhibitors: Funding, Investors & Team (Sep 2026)
Hexigone aims to replace toxic chemicals used in the anti-corrosion market with our disruptive, novel, micro/nano reservoir technologies, creating 'smart' coatings. Our additives will enable the coatings to protect for longer in an intelligent manner, increasing the lifetime cycle of the end product, reducing the drain on primary resources.
Hexigone Inhibitors has raised $1.6M across 1 funding round on record, the most recent a Seed of $1.6M announced in Jun 2026.
That round is below the $6.0M median round size for Science and Engineering companies tracked on FundedIQ over the last two years.
Hexigone Inhibitors Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Hexigone Inhibitors Funding Rounds
Hexigone Inhibitors Founders and Leadership Team
No contact details are on record for this team yet.
Hexigone Inhibitors Funding Compared to Other Science and Engineering Startups
Hexigone Inhibitors' latest round of $1.6M is below the median round in Science and Engineering. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Hexigone Inhibitors in Science and Engineering and Wales
Companies Similar to Hexigone Inhibitors
Delta Gold Technologies is creating intellectual property ("IP") for the quantum computing sector under an…
Applied Atomics is a european aerospace and defense company that develops space-based transportation network.
Spaceflux is a seed-stage company founded in the UK in 2022 with the goal of addressing the issue of…
QMatter develops simulation tools for molecular modelling based on quantum compression mechanism.
Vertical is a British aerospace tech company that's pioneering electric aviation through designing and…
Storegga Geotechnologies focuses on decarbonization projects, specifically in carbon capture and storage as…
We eliminate CO2 by turning it into rock using the natural power of mineralisation.
We're fixing build-to-release management for app and game developers.
Vanguard Tech offers a comprehensive solution for the maritime industry and marine insurance market,…
CATAGEN are delivering advanced solutions that will have direct impact on our cities and air quality.…
Founded in 2015, Orbex is Europe’s leading private launch services company, focused entirely on supporting…
SRT Marine Systems PLC operates within the marine technology industry.
Hexigone Inhibitors Funding FAQs
What does Hexigone Inhibitors do?
Hexigone aims to replace toxic chemicals used in the anti-corrosion market with our disruptive, novel, micro/nano reservoir technologies, creating 'smart' coatings. Our additives will enable the coatings to protect for longer in an intelligent manner, increasing the lifetime cycle of the end product, reducing the drain on primary resources.
How much funding has Hexigone Inhibitors raised?
Hexigone Inhibitors has raised $1.6M across 1 round on record. The most recent is a Seed of $1.6M announced in Jun 2026.
When did Hexigone Inhibitors last raise funding?
Hexigone Inhibitors' most recent funding round on record is a Seed of $1.6M, announced in Jun 2026.
Who founded Hexigone Inhibitors?
FundedIQ lists Patrick Dodds (Founder) at Hexigone Inhibitors.
Where is Hexigone Inhibitors headquartered?
Hexigone Inhibitors is based in Wales, Cumbria, United Kingdom.
How many employees does Hexigone Inhibitors have?
Hexigone Inhibitors is in the 1-10 employee band.
How does Hexigone Inhibitors' funding compare to other Science and Engineering startups?
Hexigone Inhibitors' latest round of $1.6M is below the $6.0M median round size for Science and Engineering companies on FundedIQ across 232 tracked companies over the last two years.
About FundedIQ's Hexigone Inhibitors Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Hexigone Inhibitors is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.